GHTC submitted written testimony to the Senate Labor, Health and Human Services (LHHS) Appropriations Subcommittee urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY21) budget.
PDF
GHTC endorsed a sign-on letter from the Infectious Diseases Society of America (ISDA) urging the US government to engage with the Access to COVID-19 Tools Accelerator (ACT Accelerator), a global initiative designed to drive the development and availability of COVID-19 vaccines.
PDF
POZ quoted a GHTC tweet in an article on HIV Vaccine Awareness Day 2020.
View
The Global Health Technologies Coalition issued the following statement in advance of the 73rd World Health Assembly, which will be held virtually May 18–19.
Learn more
As a member of the Global Health Council's (GHC) delegation for the 73rd World Health Assembly, GHTC joined GHC in its statement from civil society supporting the World Health Organization's leadership role in coordinating the COVID-19 global response and urging member states to support research for and equitable access to coronavirus drugs, vaccines, diagnostics, and other health products.
PDF
Global Health Now featured a commentary from GHTC Director Jamie Bay Nishi which makes the case for why the US Agency for International Development should be funded to play a larger role in the research response to COVID-19.
View
GHTC endorsed an NGO sign on letter urging Congressional appropriators to sustain support for United Nations (UN) entities in the fiscal year 2021 (FY21) appropriations bill.
PDF
GHTC signed on to letters from the tuberculosis (TB) advocacy community urging Congressional appropriators to provide additional resources for US TB programs in the next COVID-19 response legislation to reduce the detrimental impact of the pandemic on these programs.
Learn more